2014 NCCN Congress Series™: Utilizing Guidelines to Customize Patient Care in NSCLC - New Recommendations for Lung Cancer Screening and Follow-up
Lung cancer is the leading cause of cancer death in the United States. Oncologists need to be aware of new treatment options and recommendations so they can implement the best treatment plans and thus improve outcomes for their patients with lung cancer. The 2014 NCCN Congress Series™: Utilizing Guidelines to Customize Patient Care in Non-Small Cell Lung Cancer will discuss the most recent developments in diagnosis and treatment to ensure that members of a multidisciplinary team, including physicians, nurses, pharmacists and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practice and healthcare setting for patients with non-small cell lung cancer.
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other healthcare professionals who manage patients with non-small cell lung cancer.
Following this activity, participants should be able to:
- Outline the criteria for assessing whether patients are at high risk for lung cancer and thus are candidates for lung cancer screening
- Describe the benefits and risks of lung cancer screening
- Apply the currently recommended NCCN screening and follow-up guidelines for lung cancer
Ella Kazerooni, MD
University of Michigan Comprehensive Cancer Center
This activity is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided. View complete accreditation information
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician